224
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 4077-4083 | Published online: 02 Oct 2021

References

  • Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.264832091533
  • WHO. COVID-19 Update. Vol. 2021. 6, 2021.
  • Jeon M, Kim J, Oh CE, Lee J-Y. Adverse events following immunization associated with coronavirus disease 2019 vaccination reported in the mobile vaccine adverse events reporting system. J Korean Med Sci. 2021;36(17). doi:10.3346/jkms.2021.36.e114
  • Abdulla ZA, Al-Bashir SM, Al-Salih NS, Aldamen AA, Abdulazeez MZ. A summary of the SARS-CoV-2 vaccines and technologies available or under development. Pathogens. 2021;10(7):788. doi:10.3390/pathogens1007078834206507
  • Sathian B, Asim M, Banerjee I, et al. Development and implementation of a potential coronavirus disease 2019 (COVID-19) vaccine: a systematic review and meta-analysis of vaccine clinical trials. Nepal J Epidemiol. 2021;11(1):959. doi:10.3126/nje.v11i1.3616333868742
  • Meo S, Bukhari I, Akram J, Meo A, Klonoff D. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and moderna vaccines. Eur Rev Med Pharmacol Sci. 2021;25(3):1663–1669.33629336
  • Mascellino MT, Di Timoteo F, De Angelis M, Oliva A. Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect Drug Resist. 2021;14:3459. doi:10.2147/IDR.S31572734511939
  • Kyriakidis NC, López-Cortés A, González EV, Grimaldos AB, Prado EO. SARS-CoV-2 vaccines strategies: a comprehensive review of Phase 3 candidates. Npj Vaccines. 2021;6(1):1–17. doi:10.1038/s41541-021-00292-w33398010
  • Gee J, Marquez P, Su J. First month of COVID-19 vaccine safety monitoring — United States, December 14, 2020–January 13, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(8):283–288. doi:10.15585/mmwr.mm7008e333630816
  • Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111.33306989
  • Hatmal MMM, Al-Hatamleh MA, Olaimat AN, et al. Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, Cross-Sectional Study implementing machine learning for predicting severity of side effects. Vaccines. 2021;9(6):556. doi:10.3390/vaccines906055634073382
  • Shekhar R, Sheikh AB, Upadhyay S, et al. COVID-19 vaccine acceptance among health care workers in the United States. Vaccines. 2021;9(2):119. doi:10.3390/vaccines902011933546165
  • COVID C. Response TeamFood and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(2):46–51. doi:10.15585/mmwr.mm7002e133444297
  • Carli G, Nichele I, Ruggeri M, Barra S, Tosetto A. Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Intern Emerg Med. 2021;16(3):803–804. doi:10.1007/s11739-021-02685-033687691
  • Farooq F, Rathore FA. COVID-19 vaccination and the challenge of infodemic and disinformation. J Korean Med Sci. 2021;36:10. doi:10.3346/jkms.2021.36.e78
  • Control CfD, Prevention. Possible Side Effects After Getting a COVID-19; vaccine; 2021.
  • El-Shitany NA, Harakeh S, Badr-Eldin SM, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021;14:1389. doi:10.2147/IJGM.S31049733907443
  • Sah R, Shrestha S, Mehta R, et al. AZD1222 (Covishield) vaccination for COVID-19: experiences, challenges and solutions in Nepal. Travel Med Infect Dis. 2021. doi:10.1016/j.tmaid.2021.101989
  • Huh K, Kim Y-E, Radnaabaatar M, et al. Estimating baseline incidence of conditions potentially associated with vaccine adverse events: a call for surveillance system using the Korean National Health Insurance Claims Data. J Korean Med Sci. 2021;36(9):9. doi:10.3346/jkms.2021.36.e67
  • Wise J. Covid-19: European Countries Suspend Use of Oxford-AstraZeneca Vaccine After Reports of Blood Clots. British Medical Journal Publishing Group; 2021.
  • Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21(7):939–949. doi:10.1016/S1473-3099(21)00224-333930320